Xiaole Shirley Liu

Xiaole Shirley Liu has an extensive work experience primarily in the field of biostatistics and computational biology. Xiaole Shirley is currently serving as the Chief Executive Officer at GV20 Therapeutics since February 2022. Prior to this, they had a long career at the Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health, where they held various roles. From April 2012 to January 2022, they worked as a Professor of Biostatistics and Computational Biology. Before that, they served as an Associate Professor from January 2008 to April 2012 and as an Assistant Professor from July 2003 to December 2007. Xiaole Shirley also worked as an Independent Fellow from July 2002 to June 2003.

Xiaole Shirley Liu's education history begins with their time at Peking University from 1992 to 1994. During this period, they studied Biochemistry. Following their studies at Peking University, they attended Smith College from 1994 to 1997, where they pursued a Bachelor of Arts degree in Biochemistry and Computer Science. Finally, from 1997 to 2002, Xiaole Shirley Liu enrolled in Stanford University, where they obtained a Doctor of Philosophy (PhD) degree in Biomedical informatics and Computer Science.